BioCentury
ARTICLE | Financial News

Charles River ups earnings guidance

June 14, 2001 7:00 AM UTC

CRL, a provider of research tools and support services for drug discovery and development, raised its second quarter EPS estimates to $0.21-$0.22 from $0.18-$0.20. Second quarter sales are expected to...